Merck & Co annual debt-to-assets ratio
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Merck & Co's debt-to-assets ratio was 0.37 for fiscal 2025.
View full Merck & Co company overview| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.37 | 0.04 | +12.93% |
| 2024 | 2024-12-31 | 0.33 | −0.01 | −4.03% |
| 2023 | 2023-12-31 | 0.34 | 0.05 | +16.14% |
| 2022 | 2022-12-31 | 0.29 | −0.03 | −10.54% |
| 2021 | 2021-12-31 | 0.33 | −0.04 | −10.23% |
| 2020 | 2020-12-31 | 0.36 | 0.04 | +12.81% |
| 2019 | 2019-12-31 | 0.32 | 0.02 | +6.51% |
| 2018 | 2018-12-31 | 0.30 | 0.03 | +9.39% |
| 2017 | 2017-12-31 | 0.28 | 0.02 | +6.79% |
| 2016 | 2016-12-31 | 0.26 | 0.00 | +0.14% |
| 2015 | 2015-12-31 | 0.26 | 0.04 | +19.11% |
| 2014 | 2014-12-31 | 0.22 | −0.02 | −8.25% |
| 2013 | 2013-12-31 | 0.24 | 0.04 | +22.41% |
| 2012 | 2012-12-31 | 0.19 | 0.03 | +16.60% |
| 2011 | 2011-12-31 | 0.17 | −0.00 | −1.53% |
| 2010 | 2010-12-31 | 0.17 | 0.01 | +8.66% |
| 2009 | 2009-12-31 | 0.16 | 0.02 | +17.67% |
| 2008 | 2008-12-31 | 0.13 | — | — |
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.42 | 0.11 | +37.86% |
| Q1 2026 | 2026-03-31 | 0.38 | 0.08 | +26.22% |
| Q4 2025 | 2025-12-31 | 0.37 | 0.04 | +12.93% |
| Q3 2025 | 2025-09-30 | 0.32 | −0.00 | −1.42% |
| Q2 2025 | 2025-06-30 | 0.30 | −0.03 | −10.25% |
| Q1 2025 | 2025-03-31 | 0.30 | −0.02 | −6.44% |
| Q4 2024 | 2024-12-31 | 0.33 | −0.01 | −4.03% |
| Q3 2024 | 2024-09-30 | 0.32 | −0.00 | −0.87% |
| Q2 2024 | 2024-06-30 | 0.34 | −0.02 | −4.98% |
| Q1 2024 | 2024-03-31 | 0.32 | 0.04 | +13.45% |
| Q4 2023 | 2023-12-31 | 0.34 | 0.05 | +16.14% |
| Q3 2023 | 2023-09-30 | 0.33 | 0.04 | +15.18% |
| Q2 2023 | 2023-06-30 | 0.35 | 0.06 | +19.33% |
| Q1 2023 | 2023-03-31 | 0.28 | −0.01 | −4.47% |
| Q4 2022 | 2022-12-31 | 0.29 | −0.03 | −10.54% |
| Q3 2022 | 2022-09-30 | 0.28 | 0.00 | +0.54% |
| Q2 2022 | 2022-06-30 | 0.30 | 0.00 | +1.30% |
| Q1 2022 | 2022-03-31 | 0.30 | −0.05 | −13.47% |
| Q4 2021 | 2021-12-31 | 0.33 | −0.04 | −10.23% |
| Q3 2021 | 2021-09-30 | 0.28 | −0.04 | −11.65% |
| Q2 2021 | 2021-06-30 | 0.29 | −0.05 | −14.31% |
| Q1 2021 | 2021-03-31 | 0.34 | 0.01 | +4.48% |
| Q4 2020 | 2020-12-31 | 0.36 | 0.04 | +12.81% |
| Q3 2020 | 2020-09-30 | 0.32 | −0.01 | −1.80% |
| Q2 2020 | 2020-06-30 | 0.34 | 0.01 | +3.77% |
| Q1 2020 | 2020-03-31 | 0.33 | 0.00 | +0.86% |
| Q4 2019 | 2019-12-31 | 0.32 | 0.02 | +6.51% |
| Q3 2019 | 2019-09-30 | 0.33 | 0.05 | +17.40% |
| Q2 2019 | 2019-06-30 | 0.33 | 0.05 | +19.94% |
| Q1 2019 | 2019-03-31 | 0.33 | 0.05 | +19.20% |
| Q4 2018 | 2018-12-31 | 0.30 | 0.03 | +9.39% |
| Q3 2018 | 2018-09-30 | 0.28 | −0.02 | −5.87% |
| Q2 2018 | 2018-06-30 | 0.27 | 0.01 | +2.12% |
| Q1 2018 | 2018-03-31 | 0.27 | −0.02 | −7.07% |
| Q4 2017 | 2017-12-31 | 0.28 | 0.02 | +6.79% |
| Q3 2017 | 2017-09-30 | 0.29 | 0.04 | +15.38% |
| Q2 2017 | 2017-06-30 | 0.27 | 0.02 | +6.52% |
| Q1 2017 | 2017-03-31 | 0.30 | 0.03 | +12.98% |
| Q4 2016 | 2016-12-31 | 0.26 | 0.00 | +0.14% |
| Q3 2016 | 2016-09-30 | 0.26 | −0.01 | −3.22% |
| Q2 2016 | 2016-06-30 | 0.25 | −0.01 | −2.86% |
| Q1 2016 | 2016-03-31 | 0.26 | −0.02 | −6.27% |
| Q4 2015 | 2015-12-31 | 0.26 | 0.04 | +19.11% |
| Q3 2015 | 2015-09-30 | 0.26 | −0.01 | −3.41% |
| Q2 2015 | 2015-06-30 | 0.26 | 0.02 | +9.85% |
| Q1 2015 | 2015-03-31 | 0.28 | 0.02 | +7.59% |
| Q4 2014 | 2014-12-31 | 0.22 | −0.02 | −8.25% |
| Q3 2014 | 2014-09-30 | 0.27 | 0.02 | +9.24% |
| Q2 2014 | 2014-06-30 | 0.24 | −0.03 | −10.22% |
| Q1 2014 | 2014-03-31 | 0.26 | 0.06 | +32.28% |
| Q4 2013 | 2013-12-31 | 0.24 | 0.04 | +22.41% |
| Q3 2013 | 2013-09-30 | 0.25 | 0.07 | +35.56% |
| Q2 2013 | 2013-06-30 | 0.26 | 0.08 | +46.03% |
| Q1 2013 | 2013-03-31 | 0.20 | 0.02 | +13.80% |
| Q4 2012 | 2012-12-31 | 0.19 | 0.03 | +16.60% |
| Q3 2012 | 2012-09-30 | 0.18 | 0.01 | +8.24% |
| Q2 2012 | 2012-06-30 | 0.18 | 0.01 | +4.45% |
| Q1 2012 | 2012-03-31 | 0.17 | 0.00 | +2.09% |
| Q4 2011 | 2011-12-31 | 0.17 | −0.00 | −1.53% |
| Q3 2011 | 2011-09-30 | 0.17 | 0.00 | +1.22% |
| Q2 2011 | 2011-06-30 | 0.17 | 0.00 | +1.77% |
| Q1 2011 | 2011-03-31 | 0.17 | −0.00 | −1.53% |
| Q4 2010 | 2010-12-31 | 0.17 | 0.01 | +8.66% |
| Q3 2010 | 2010-09-30 | 0.17 | −0.10 | −37.45% |
| Q2 2010 | 2010-06-30 | 0.17 | −0.11 | −38.74% |
| Q1 2010 | 2010-03-31 | 0.17 | — | — |
| Q4 2009 | 2009-12-31 | 0.16 | 0.02 | +17.67% |
| Q3 2009 | 2009-09-30 | 0.27 | — | — |
| Q2 2009 | 2009-06-30 | 0.28 | — | — |
| Q4 2008 | 2008-12-31 | 0.13 | — | — |
Over the last five fiscal years, Merck & Co's debt-to-assets ratio increased from 0.36 to 0.37, a change of 0.00. The latest reported quarter, Q2 2026, shows 0.42.
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Merck & Co source filings ↗